Global Impact Of Covid-19 On Anti-Infective Drugs Market To Record Significant Revenue Growth During The Forecast Period 2020–2022

Anti-Infective Drugs Market - By Type Of Product (Antibiotics, Antivirals, Antifungals And Others (Including Anthelminthic And Antiprotozoal Drugs)), And By Region, Opportunities And Strategies – Global Forecast To 2022 By The Business Research Company

The global anti-infective drugs market reached a value of nearly $88.5 billion in 2018, having grown at a compound annual growth rate of 7.0% since 2014. Growth in the historic period resulted from rise in the incidence rates of infectious diseases, aging population and growth of emerging markets. Factors that negatively affected growth in the historic period were low returns of investment, pricing pressures from regulators and patent expiration of drugs.

The Key drivers of the anti-infective drugs market include:-
Developments In Drug Discovery Procedures: The anti-infective drugs market is expected to benefit from the latest developments in drug discovery procedures such as stem cells and organ-on-chip (OOC) technologies. OOCs are micro-engineered biometric systems that simulate the activities, mechanics and physiological responses of organ systems. Drug trial processes such as target identification, validation, and screening are being executed through OOC and stem cell technologies. These technologies are considerably reducing the drug discovery costs and generating reliable predictions on drug efficiency and human safety.

Browse Complete Report @ https://www.thebusinessresearchcompany.com/report/anti-infective-drugs-market

Anti-Infective Drugs Market Segmentation:-
By Product Type
1. Antibiotics
2. Antivirals
3. Antifungals
4. Others (Anthelminthic, Antiprotozoal)

Antivirals had the highest growth rate of nearly 7.4% during the historic period. The fastest market growth can be attributed to rapid increase in the access to antiviral treatment of sexually transmitted diseases such as Hepatitis B and HIV/AIDS.

Request For A Sample Copy Of This Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=2348&type=smp

By Geography - The anti-infective drugs market is segmented into
1.North America
2.Western Europe
3.Asia Pacific
4.Eastern Europe
5.South America
6.Middle East
7.Africa

North America was the largest market for anti-infective drugs, accounting for a 47.7% of the global market in 2018. It was followed by Western Europe, Asia-Pacific and then the other regions. Going forward, Africa and Middle East will be the fastest growing regions in this market.

Some of the major key players involved in the anti-infective drugs market are
1. Gilead Sciences
2. GlaxoSmithKline plc
3. Merck & Co.
4. Teva Pharmaceutical Industries Ltd.
5. Johnson & Johnson

Place a DIRECT PURCHASE ORDER of the report @ https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2348

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on Blog: http://blog.tbrc.info/

About US:
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets after WHO declared COVID-19 as a pandemic.

This release was published on openPR.